BPC-157 deep dive · research transcript

BPC-157 (Body Protection Compound-157)

BPC-157 is a synthetic 15-amino-acid fragment of an endogenous body-protection sequence. Studied for tendon, ligament, and soft-tissue recovery pathways, it appears in the literature as a focused probe of the regenerative signaling cascade — referenced in wound-healing and angiogenic growth-factor research rather than systemic outcomes.

Batch
…
Purity
…
Vial
…
Lab
…
Compound VialSee the molecule

Vial & molecule

Drag either viewer to rotate, scroll or use +/− to zoom. Both degrade to a static card on mobile or when the browser suppresses motion.

See the moleculeFetching the structure descriptor for this compound.

Loading the Certificate of Analysis…

Resolving batch LAB-2614 against the public lab record.

Loading Lab Insights…
Verify this vial

Batch LAB-2614 resolves against the public Certificate of Analysis.

The same lookup tool lives at /verify — paste a different batch ID below to swap the resolved record inline.

Sample batches

Resolving the requested batch ID…

How to read this Certificate of Analysis

Five fields, plain English.

  1. Batch ID

    The lookup key — printed on the vial label and on the public certificate. Type it into the input above to swap to NAD+, Semaglutide, or any other assay in this run.

  2. Third-party lab

    Apex Veritas Analytical — ISO/IEC 17025-accredited, not an in-house assay. The lab name on the certificate is the auditing point of record; the printed batch resolves against the lab report, not a marketing claim.

  3. Purity %

    Reported from HPLC — the industry-standard identity + purity assay for this peptide class. The chromatogram is the visual proof: the printed percentage is the integrated area of the dominant peptide peak against the total integrated area.

  4. Test date

    The calendar date the assay was run — distinct from the manufacturing date. A recent test date means the certificate reflects the vial as it sits on the shelf today, not a snapshot from months ago.

  5. Residual solvent

    Trace synthesis solvent carried through the purification step, reported in parts-per-million against the ICH Q3C safety threshold. A clean residual-solvent panel reads as a left-over signature of how thoroughly the crude fragment was purified.

How this batch was made

Three steps from synthesis to a signed certificate.

Synthesis

Solid-phase peptide synthesis assembles the 15-amino-acid sequence on a resin support using a repeated deprotection / coupling cycle, then a final cleavage yields the crude linear fragment.

HPLC

Reverse-phase high-performance liquid chromatography is the identity + purity assay; the chromatogram is the visual proof that the right peptide is the dominant peak. The 99.4% printed on the certificate is the integrated area of that peak against the total integrated area.

Mass spec

Electrospray ionization mass spectrometry is the identity confirmation; the observed molecular ion mass is read against the theoretical monoisotopic mass so the framework of the recovered peptide matches the sequence on file.

Related compounds

Other research lineages in this catalog.

Recovery peer · NAD+

NAD+ (Nicotinamide Adenine Dinucleotide)

Mitochondrial electron-transport cofactor studied for redox balance, sirtuin activation, and PARP-family DNA-repair signaling.

Read the NAD+ research hub
Metabolic peer · Semaglutide

Semaglutide (Long-acting GLP-1 analogue)

Long-acting incretin analogue researched for sustained satiety signaling and glucose-handling pathways.

Read the Semaglutide research hub
Order this batch

Add the same batch to your cart from one place.

Pick the vial size from the current catalog row. Every price below is for one sealed 10-vial pack, and the current batch remains visible beside the ordering actions.

Current batchLAB-2614· CoA verified
Loading the order block…